psychosis Schizophrenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients (treated with clozapine or haloperidol or untreated) with a diagnosis of *first episode psychosis*, suggestive for the diagnosis schizophrenia are eligible to participate in the study. Age between 18 and 40 years
Exclusion criteria
Exclusion criteria: Any neurological, cardiovascular, and respiratory diseases; claustrophobia, pregnancy; other relevant psychiatric disorders; MRI contraindications. Subjects will also be excluded when they cannot understand the Dutch language sufficiently to understand the purposes and implications of the experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Group differences in pattern or intensity of activation between the group of patients and healthy controls as measured by fMRI. Influence of medication on pattern or intensity of activation in the group of patients with schizophrenia | — |
Secondary
| Measure | Time frame |
|---|---|
| None. | — |
Countries
Netherlands